EIS-12656

· Eisbach Bio GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EIS-12656, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors [Phase 1, Phase 2]